MR Imaging to predict complete cytoreduction and survival in colorectal peritoneal metastases in patients considered for CRS/HIPEC

(1) The Netherlands Cancer Institute,Amsterdam,Netherlands



This item was part of the Oesophageal, Gastric and Duodenal Disorders III (Posters) session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019